Exercise During Hemodialysis: Impact on Sarcopenia and Sleep Quality
Recruiting
N/A
Interventional Study
Sarcopenia
Renal Insufficiency, Chronic
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 40 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 58 (estimated)
- Sponsor
- University of Salamanca · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Sarcopenia (the loss of muscle mass, strength, and function) is highly prevalent in patients with Chronic Kidney Disease (CKD) undergoing hemodialysis, significantly increasing the risk of falls, frailty, and mortality. Despite its impact, there is a lack of evidence regarding the effectiveness of exercise programs specifically designed to address sarcopenia under the latest international diagnost…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Subjects currently enrolled in a Chronic Hemodialysis Unit.
* Patients who have been on hemodialysis treatment for more than 3 months.
* Subjects aged 40 years or older.
* Hemoglobin levels greater than 10 mg/dl.
* Ability to perform physical fitness assessment tests or dynamo…
Contacts